companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

ACCELERON

SAINT-LAURENT-Canada

Company Name:
Corporate Name:
ACCELERON
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 5003 Rue Levy,SAINT-LAURENT,QC,Canada 
ZIP Code:
Postal Code:
H4R 
Telephone Number: 5143310007 
Fax Number:  
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
270199 
USA SIC Description:
COMPUTER SALES & SERVICES 
Number of Employees:
5 to 9 
Sales Amount:
$1 to 2.5 million 
Credit History:
Credit Report:
Good 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
ACCENT HOME PRODUCTS LTD
ACCENT HOLT MANUFACTURING
ACCENT CREATIONS BIJOUTIER FABRI
Next company profile:
ACCELERON INC
ACCADEMIA QUALITAS INC
ACADEMIE SANTE BEAUTE MBD INC










Company News:
  • Accelleron – The future of turbocharging today
    At Accelleron, we continuously innovate to deliver turbocharging, fuel injection, and digital technologies that accelerate sustainability at sea, on land and beyond
  • Acceleron Pharma - Wikipedia
    Acceleron Pharma, Inc is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle
  • We are Accelleron
    We help the world move further, more efficiently and sustainably As a global leader in turbocharging, fuel injection, and digital solutions for heavy-duty applications, our technologies and services support marine and energy industries that form the backbone of modern civilization
  • Acceleron® Seed Applied Solutions | Crop Science US - Bayer
    The Acceleron ® portfolio is the most advanced seed treatment solution in the industry Powerful bio-enhancers protect against nutrient and moisture stress, while chemical seed treatments defend against threats like nematodes, insects and diseases
  • Merck to Acquire Acceleron Pharma Inc. - Merck. com
    Acceleron focuses its research, development, and commercialization efforts in pulmonary and hematologic diseases In pulmonary, Acceleron is developing sotatercept for the treatment of pulmonary hypertension (PH)
  • Accelleron – the new face of ABB Turbocharging | News center
    New brand first step on company's journey towards separate value creation; Accelleron conveys ambition “to succeed and move further” ABB today announced that its Turbocharging division (PA), a global leader in heavy duty turbocharging for diesel and gas engines, has unveiled its new brand name “Accelleron”, a compound word of: Access – Accelerate – Excel – on and on, with a bold
  • Merck confirms $11. 5bn Acceleron takeover deal - pharmaphorum
    After days of speculation, Merck Co confirmed today that it has agreed to acquire Acceleron Pharma $1 5 billion, setting up what could be one of the largest biopharma acquisitions of 2021 so
  • Merck to buy drugmaker Acceleron for about $11. 5 billion
    Merck is buying Acceleron Pharma for about $11 5 billion, broadening its portfolio beyond aging cancer drug Keytruda
  • Merck Completes Acquisition of Acceleron Pharma Inc.
    Acceleron’s lead therapeutic candidate, sotatercept, has a novel mechanism of action with the potential to improve short-term and or long-term clinical outcomes in patients with pulmonary arterial hypertension (PAH), a progressive and life-threatening blood vessel disorder
  • Merck’s $11. 5bn Acquisition of Acceleron Pharma - MergerSight Group
    Merck, through a subsidiary, will acquire Acceleron, a clinical-stage biopharmaceutical company focused on rare diseases for $11 5 billion Merck is a multinational pharmaceutical company known most for its product Keytruda, a medication used to treat various types of cancer




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer